Infectious Disease Control
Future Uncertainty Hangs Heavy in Cigna COVID-19 Study
HONG KONG, Dec. 17, 2020 /PRNewswire/ -- Cigna's (NYSE:CI) International
Markets business today published the fourth edition of itsCOVID-19 Global
Impact Study
E-Tech's ALTANT Ozonized Alcohol Disinfectant Shown to Inactivate Both Novel Coronavirus and Swine Fever Virus, World's First
KOBE, Japan, Dec. 16, 2020 /PRNewswire/ -- Joint research between E-Tech Co., Ltd. and Obihiro University of Agriculture and Veterinary Medicine has verified the ability of ALTANT ozonized alcohol disinfectant to inactivate COVID-19. E-Tech's joint research withHokkaido University has also verif...
Senecio Robotics awarded US$12 Million from the European Commission to address mosquito borne diseases
TEL AVIV, Israel, Dec. 16, 2020 /PRNewswire/ -- With more than 2,000 early
stage companies applying for the EU EIC Accelerator Pilot May cutoff,only 64
companies were selected
More than 10 million additional children under 5 will suffer from malnutrition in next two years due to COVID-19
Global leaders commit more than US$3 billion to address hunger and nutrition crisis OTTAWA, Ontario, Dec. 16, 2020 /PRNewswire/ -- The Governments of Canada and Bangladesh, in partnership with the Government of Japan, on Monday hosted a virtual launch of theNutrition for Growth Year of Action, s...
AIDA Cruises uses temperature detection by DERMALOG
ROSTOCK and HAMBURG, Germany, Dec. 15, 2020 /PRNewswire/ -- AIDA Cruises has implemented the contactless Body Temperature Camera from the German company DERMALOG as part of its health and hygiene concept. DERMALOG's solution measures body temperature in real-time using state-of-the-art sensor te...
Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation
TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...
China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers
SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- On December 13, 2020, the "Love & Hope" Gala Concert, organized by Huaxia Cultural Hub, was held in the Singapore Conference Hall, presenting a wonderful musical performance for locals. China Life Insurance (Singapore) Pte. Ltd. ("China Life Singapore")pro...
TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors
BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...
NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'
SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...
NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'
SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...
Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates
SUZHOU, China, Dec. 12, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for the treatment of COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutica...
Kintor Pharmaceutical Announces Preliminary Results from the Proxalutamide's Clinical Trial
SUZHOU, China, Dec. 11, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutical and is currentl...
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("...
Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
BEIJING, Dec. 10, 2020 /PRNewswire/ -- A statement on strengthening media cooperation issued by China Media Group (CMG) and its European media partners, calling on the Chinese and European media to fulfill their responsibilities as public information disseminators and jointly help the internat...
InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization
BOULDER, Colo., Dec. 10, 2020 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike ...
New Travel Health and Safety Protocols Implemented in Bali to Welcome Back Global Visitors
JAKARTA, Indonesia, Dec. 10, 2020 /PRNewswire/ -- Having seen an increase numbers of tourists, The Ministry of Tourism and Creative Economy (MoTCE) of Indonesia has made massive strides to ensure a safe Cleanliness, Health, Safety, and Environmental Sustainability (CHSE) protocols inBali. Namely ...
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world
Gates Foundation pledges additional $250 million to accelerate development and equitable distribution of COVID-19 tests, treatments, and vaccines to end the pandemic SEATTLE, Dec. 10, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced it will commit an additional$250 millio...
Beijing Forum 2020 shines a spotlight on new challenges and opportunities of globalization
BEIJING, Dec. 10, 2020 /PRNewswire/ -- The Beijing Forum 2020 opened at Peking University onDecember 5, with bilingual live broadcasts across multiple platforms. This year, the international academic event, co-organized by Peking University, Beijing Municipal Education Commission, and Chey Instit...
Cybernet on the Front Lines of Massive Vaccination Program
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- All eyes are on the United Kingdom today as they are the first western country in the world to begin to issue COVID-19 vaccinations. This ambitious undertaking, which has been dubbed the largest mass-vaccination program in the country's history, will ...
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00Hyundai Motor Group Fosters Collaboration with Hydrogen Industry Leaders at Hydrogen Council Global CEO Summit
[Picked up by 295 media titles]
2025-12-04 15:00